Loading
In England the offer has four named parts: an assessment of what you need and a plan written with you, information and support about living well, a summary of your treatment sent to you and your GP, and a review with your GP. Follow-up is increasingly not a routine clinic appointment but a pathway you manage yourself, with tests at set intervals and a route back in.
The English model is built around personalised care and support planning rather than around a single document. Macmillan Cancer Support, which developed it with the NHS, names four interventions.
The holistic needs assessment and the personalised care and support plan. The assessment covers physical, practical, emotional and social concerns, and the resulting plan is described as ensuring that "people's physical, practical, emotional and social needs are identified and addressed at the earliest opportunity". It is meant to happen more than once, at diagnosis, at the end of treatment and at any change.
The end of treatment summary. "A Treatment Summary is a document produced by the hospital clinician at the end of initial treatment for cancer." It goes to the patient and to their general practice, and it is the mechanism by which primary care learns what the person had, what to watch for and what to do about it.
The cancer care review in primary care. "A Cancer Care Review (CCR) is a conversation between a patient and their GP or Practice Nurse about their cancer journey." It is contractually incentivised: the Quality and Outcomes Framework requires these reviews "at the time of a patient's diagnosis (within 3 months) and after a patient has received acute treatment (within 12 months)".
Health and wellbeing information and support, meaning the events, written material and signposting that help a person understand what has happened and what to do next.
Personalised stratified follow-up. The structural change is that routine follow-up appointments for many cancers have been replaced by risk-stratified pathways: supported self-management with scheduled surveillance tests and a fast route back to the team if something changes, for people at lower risk of recurrence; shared or professional-led follow-up for those at higher risk. Breast, prostate and colorectal cancer were the first pathways. The clinical case for this is that routine appointments rarely detect recurrence, and the risk is that a person who feels discharged has nobody to tell. Qualitative work with clinicians implementing risk-stratified follow-up in lung cancer found receptivity alongside specific worries: staffing shortages, unclear roles, varying patient preferences and limited health literacy, concerns about reduced clinical autonomy and patient safety, and the need for evidence of effectiveness and aligned reimbursement.
Measurement attached to it. The UK has run population outcome studies after treatment at a scale few health systems attempt: the Life After Prostate Cancer Diagnosis study collected EQ-5D-5L and the prostate-specific EPIC-26 from 35,823 men across the UK 18 to 42 months after diagnosis, and resurveyed 28,450 of them a year later with an 85.8 per cent response. England also runs a national survey of quality of life after a cancer diagnosis; we could not reach its data pages in this round, so its design, coverage and results are not described here.
What the offer does not include, and what we could not verify. The parts above are what is supposed to happen; this record does not assert a national figure for how many people actually receive each one, because we could not source a current published rate from NHS England directly during this round. The devolved nations run their own versions with different names, and we have not verified them here. Rehabilitation, psychological therapy and lymphoedema services are commissioned locally and vary between areas, which is where the inequity record picks the story up.
Risk-stratify follow-up by recurrence risk and capacity to self-manage; replace routine surveillance appointments with scheduled tests plus supported self-management and a guaranteed route back; transfer the information to primary care through a written treatment summary and a contracted review; and assess need holistically rather than by disease alone.
Query for this technology: (TITLE:"After treatment in the UK: personalised care, and follow-up you lead yourself" OR ABSTRACT:"After treatment in the UK: personalised care, and follow-up you lead yourself") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about After treatment in the UK: personalised care, and follow-up you lead yourself, not a curated reading list.
Shares After treatment in Australia: a stated model of survivorship care, Referral to rehabilitation: the service most people who need it never see, Who misses out on recovery care, measured, Not enough oncologists, nurses, pathologists, physicists and the tags rejuvenation, survivorship, measurement, access.
Shares After treatment in the Nordic countries: rehabilitation written into the pathway, After treatment in Germany: a rehabilitation entitlement, not a leaflet, What recovery costs in the UK, and what it does not, Quality of life and the tags rejuvenation, survivorship, measurement, access.
Shares What recovery costs in the UK, and what it does not, Who misses out on recovery care, measured, Fragmented care and guideline gaps, Late effects and survivorship toxicity and the tags rejuvenation, survivorship, measurement, access.
Shares Who misses out on recovery care, measured, Quality of life, Survivorship care and late-effects surveillance, Late effects and survivorship toxicity and the tags rejuvenation, survivorship, measurement, access.
Shares After treatment in the United States: the survivorship care plan, and what the trial found, What recovery costs in the UK, and what it does not, Quality of life, Survivorship and late effects are neglected and the tags rejuvenation, survivorship, measurement, access.
Shares EQ-5D: health reduced to one number, and what that number is for, Who misses out on recovery care, measured, Quality of life, Survivorship care and late-effects surveillance and the tags rejuvenation, survivorship, measurement.
Shares Referral to rehabilitation: the service most people who need it never see, Compression, decongestive therapy and exercise for lymphoedema, Quality of life, Late effects and survivorship toxicity and the tags rejuvenation, survivorship, measurement.
Shares Long-term follow-up in the United Kingdom: what a survivor is actually offered, Macmillan Cancer Support, Getting psychological help after cancer: the stepped-care model, and what is actually commissioned, Survivorship care and late-effects surveillance and the tags rejuvenation, survivorship, uk.